Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Pfeil

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Plos One|April 22, 2014
Dihydroartemisinin-piperaquine vs. artemether-lumefantrine for first-line treatment of uncomplicated malaria in African children: a cost-effectiveness analysisJohannes Pfeil, Steffen Borrmann, Yeşim Tozan
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
High-Density Peptide Arrays for Malaria Vaccine DevelopmentFelix F Loeffler, Johannes Pfeil, Kirsten Heiss
Malaria Journal|January 29, 2015
Addition of histamine to subcutaneously injected Plasmodium berghei sporozoites increases the parasite liver load and could facilitate whole-parasite vaccinationJohannes Pfeil, Jan F Heine, Ann-Kristin Mueller
BMC Research Notes|July 30, 2011
Continuous oral chloroquine as a novel route for Plasmodium prophylaxis and cure in experimental murine modelsMatthew D Lewis, Johannes Pfeil, Ann-Kristin Mueller
Plos One|February 12, 2014
CD8(+) T cells mediate robust stage-specific immunity to P. berghei under chemoprophylaxis and this protective environment is not downregulated by the presence of blood-stage infectionMatthew D Lewis, Johannes Pfeil, Kirsten Heiss, et al.
Plos One|October 8, 2014
Novel respiratory syncytial virus (RSV) genotype ON1 predominates in Germany during winter season 2012-13Julia Tabatabai, Christiane Prifert, Johannes Pfeil, et al.
BMC Infectious Diseases|December 15, 2017
Performance of the Alere i RSV assay for point-of-care detection of respiratory syncytial virus in childrenSarah Valerie Schnee, Johannes Pfeil, Clara Marlene Ihling, et al.
The American Journal of Tropical Medicine and Hygiene|August 5, 2015
An Economic Evaluation of the Posttreatment Prophylactic Effect of Dihydroartemisinin-Piperaquine Versus Artemether-Lumefantrine for First-Line Treatment of Plasmodium falciparum Malaria Across Different Transmission Settings in AfricaJohannes Pfeil, Steffen Borrmann, Quique Bassat, et al.
Journal of Clinical Microbiology|January 13, 2017
Evaluation of Alere i RSV for Rapid Detection of Respiratory Syncytial Virus in Children Hospitalized with Acute Respiratory Tract InfectionRebecca Marie Peters, Sarah Valerie Schnee, Julia Tabatabai, et al.
Orphanet Journal of Rare Diseases|October 19, 2013
Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysisJohannes Pfeil, Stefan Listl, Georg F Hoffmann, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Plos One|April 22, 2014
Dihydroartemisinin-piperaquine vs. artemether-lumefantrine for first-line treatment of uncomplicated malaria in African children: a cost-effectiveness analysisJohannes Pfeil, Steffen Borrmann, Yeşim Tozan
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
High-Density Peptide Arrays for Malaria Vaccine DevelopmentFelix F Loeffler, Johannes Pfeil, Kirsten Heiss
Malaria Journal|January 29, 2015
Addition of histamine to subcutaneously injected Plasmodium berghei sporozoites increases the parasite liver load and could facilitate whole-parasite vaccinationJohannes Pfeil, Jan F Heine, Ann-Kristin Mueller
BMC Research Notes|July 30, 2011
Continuous oral chloroquine as a novel route for Plasmodium prophylaxis and cure in experimental murine modelsMatthew D Lewis, Johannes Pfeil, Ann-Kristin Mueller
Plos One|February 12, 2014
CD8(+) T cells mediate robust stage-specific immunity to P. berghei under chemoprophylaxis and this protective environment is not downregulated by the presence of blood-stage infectionMatthew D Lewis, Johannes Pfeil, Kirsten Heiss, et al.
Plos One|October 8, 2014
Novel respiratory syncytial virus (RSV) genotype ON1 predominates in Germany during winter season 2012-13Julia Tabatabai, Christiane Prifert, Johannes Pfeil, et al.
BMC Infectious Diseases|December 15, 2017
Performance of the Alere i RSV assay for point-of-care detection of respiratory syncytial virus in childrenSarah Valerie Schnee, Johannes Pfeil, Clara Marlene Ihling, et al.
The American Journal of Tropical Medicine and Hygiene|August 5, 2015
An Economic Evaluation of the Posttreatment Prophylactic Effect of Dihydroartemisinin-Piperaquine Versus Artemether-Lumefantrine for First-Line Treatment of Plasmodium falciparum Malaria Across Different Transmission Settings in AfricaJohannes Pfeil, Steffen Borrmann, Quique Bassat, et al.
Journal of Clinical Microbiology|January 13, 2017
Evaluation of Alere i RSV for Rapid Detection of Respiratory Syncytial Virus in Children Hospitalized with Acute Respiratory Tract InfectionRebecca Marie Peters, Sarah Valerie Schnee, Julia Tabatabai, et al.
Orphanet Journal of Rare Diseases|October 19, 2013
Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysisJohannes Pfeil, Stefan Listl, Georg F Hoffmann, et al.
Pageof 3